GREENVILLE, S.C., Sept. 20 /PRNewswire-FirstCall/ -- Signalife, Inc. ("Company"), (Amex: SGN - News) announced today that it has been, and is now expanding, the shipping and delivery of its flagship, FDA-cleared, Fidelity 100 heart monitoring device. The revolutionary heart device -- which produces unparalleled data in an ambulatory setting (jogging, driving, treadmill, etc.) and thus is more capable of detecting cardiac abnormalities -- has been sold and shipped to everyone from surgeons to cardiologists to internists to, as well, a multi-billion-dollar corporation.
